Opsens Inc T.OPS

first commercial use Savvywire (TM)

[Possibleidiot01]

Key word - significant !
Timeline reiterated.

. As the TAVR procedure benefits a larger group of patients and with the minimalist approach growing in popularity within the medical community, the benefits of the SavvyWire could be significant."

Following the marketing approval received from Health Canada ahead of schedule in April 2022 , OpSens has begun a controlled release to a limited number of hospitals in Canada . U.S. Food and Drug Administration clearance is expected this fall, with full commercial launch in early 2023.

[Dogsbreakfast4U]

FDA approval is now expected in the Fall. Initially they had said late Summer or Fall.

[ddogold]

The Fall is shaping up to be transformational for us . GLTA